First Manhattan’s Insmed INSM Stock Holding History

First Manhattan’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25	Closed	-$499	–	1613
2022 Q4	$499	Hold	25	–	–	﹤0.01%	1609
2022 Q3	$0	Hold	25	–	–	﹤0.01%	1589
2022 Q2	$0	Hold	25	–	–	﹤0.01%	1613
2022 Q1	$0	Hold	25	–	–	﹤0.01%	1643
2021 Q4	$0	Hold	25	–	–	﹤0.01%	1617
2021 Q3	$0	Hold	25	–	–	﹤0.01%	1628
2021 Q2	$0	Hold	25	–	–	﹤0.01%	1576
2021 Q1	$0	Hold	25	–	–	﹤0.01%	1512
2020 Q4	$0	Hold	25	–	–	﹤0.01%	1366
2020 Q3	$0	Hold	25	–	–	﹤0.01%	1386
2020 Q2	$0	Hold	25	–	–	﹤0.01%	1421
2020 Q1	$0	Hold	25	–	–	﹤0.01%	1407
2019 Q4	$0	Hold	25	–	–	﹤0.01%	1332
2019 Q3	$0	Hold	25	–	–	﹤0.01%	1365
2019 Q2	$0	Hold	25	–	–	﹤0.01%	1407
2019 Q1	$0	Hold	25	–	–	﹤0.01%	1423
2018 Q4	$0	Hold	25	–	–	﹤0.01%	1405
2018 Q3	$0	Hold	25	–	–	﹤0.01%	1415
2018 Q2	$0	Hold	25	–	–	﹤0.01%	1385
2018 Q1	$0	Hold	25	–	–	﹤0.01%	1420
2017 Q4	$0	Hold	25	–	–	﹤0.01%	1486
2017 Q3	$0	Hold	25	–	–	﹤0.01%	1462
2017 Q2	$0	Hold	25	–	–	﹤0.01%	1427
2017 Q1	$0	Buy	+25	New	+$386	﹤0.01%	1421

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

First Manhattan's INSM Position: Q1 2023 in Review

First Manhattan sold out of Insmed (INSM) in Q1 2023, closing a stake of 25 shares — an estimated $499 sold.

First Manhattan first reported a position in INSM in Q1 2017 and held it in 24 quarters. The position peaked at $499 in Q4 2022. 230 funds tracked by Wall St. Rank hold INSM as of Q1 2023.

First Manhattan reported no remaining Insmed position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 25 Insmed shares in Q1 2023, an estimated $499.
First Manhattan first reported a position in Insmed in Q1 2017 and held it in 24 quarters.
First Manhattan's Insmed position peaked at $499 in Q4 2022.
230 funds tracked by Wall St. Rank held Insmed as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.